Industry News
Head And Neck Cancer Recurrences Detected Earlier By Routine Follow-Up Scans
Jan 29, 2012
Routine use of positron emission tomography/computed tomography (PET/CT) scans in head and neck cancer patient follow-up can detect local recurrences before they become clinically apparent and may improve the outcome of subsequent salvage therapy, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM... Read More
Discovery Of Rotational Motion Of Cells That Plays A Critical Role In Their Normal Development Has Major Implications For Breast Cancer Research
Jan 29, 2012
In a study that holds major implications for breast cancer research as well as basic cell biology, scientists with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) have discovered a rotational motion that plays a critical role in the ability of breast cells to form the spherical structures in the mammary gland known as acini... Read More
Shedding Light On Gene Destruction Linked To Aggressive Prostate Cancer
Jan 29, 2012
Researchers at Queen's University have identified a possible cause for the loss of a tumour suppressor gene (known as PTEN) that can lead to the development of more aggressive forms of prostate cancer... Read More
HPV Vaccine Not Linked To Autoimmune Disorders, Study
Jan 29, 2012
A two-year study of nearly 190,000 girls and women, finds that Gardasil, the human papillomavirus (HPV) vaccine made by Merck & Co, does not trigger autoimmune disorders such as lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis. The results are published in the Journal of Internal Medicine... Read More
HPV Vaccine Not Linked To Autoimmune Disorders, Study
Jan 28, 2012
A two-year study of nearly 190,000 girls and women, finds that Gardasil, the human papillomavirus (HPV) vaccine made by Merck & Co, does not trigger autoimmune disorders such as lupus, rheumatoid arthritis, type 1 diabetes and multiple sclerosis. The results are published in the Journal of Internal Medicine... Read More
US Cancer Screening Below National Targets
Jan 28, 2012
The percentage of people screened for cancer in the US remains below national targets for 2020, with rates lower among Asian and Hispanic Americans than other groups, according to a new report by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI) released on Friday. The report shows that in 2010, the screening rate for breast cancer was 72... Read More
Brachytherapy Alone Or In Combination With External Beam Radiation Therapy May Be An Effective Option For High-Risk Prostate Cancers
Jan 28, 2012
Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise... Read More
Researchers Discover New Therapeutic Target To Combat Liver Cancer
Jan 28, 2012
Researchers at CIC Biogune, the Cooperative Centre for Research into Biosciences and led by Dr. Maria Luz Martinez Chantar, have found a strong relationship between high levels of Hu antigen R (HuR) protein and the malignancy of Hepatocellular Carcinoma, through a novel molecular process in the investigation of this pathology and known as neddylation... Read More
Brachytherapy Alone Or In Combination With External Beam Radiation Therapy May Be An Effective Option For High-Risk Prostate Cancers
Jan 28, 2012
Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise... Read More
Inlyta (axitinib) Approved For Advanced Kidney Cancer, USA
Jan 27, 2012
The US FDA has approved Inlyta (axitinib) for the treatment of advanced renal cell carcinoma, a type of kidney cancer, in patients with whom other drugs have not been effective, the FDA (Food and Drug Administration) announced today. Inlyta is made and marketed by pharmaceutical giant Pfizer Inc... Read More
Previous Page Next Page